Study Evaluating Persistence of Anti-HBs Antibodies in Uraemic Patients Receiving Henogen's HBV Vaccine, or Fendrix™
Clinical trial NCT00445185 · COMPLETED
Trial details
- NCT number
- NCT00445185
- Sponsor
- Henogen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2009-07-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.